Dynamics of psychopharmaceutical use and relationship with psychoanalytic psychotherapy in the mental health interface: an integrative review

  • Marcio Rocha Damasceno Psicólogo, Mestre em Políticas Públicas e Desenvolvimento Local, Mestre em Psicanálise, Professor e Coordenador do Curso de Psicologia do Centro Universitário UNIFACIG – Manhuaçu (MG), /Programa de Mestrado em Políticas Públicas e Desenvolvimento Local. Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (EMESCAM). Vitória (ES),
  • Italla Maria Pinheiro Bezerra Programa de Mestrado em Políticas Públicas e Desenvolvimento Local. Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (EMESCAM). Vitória (ES)
  • Lídia Maria Nazaré Professora, Doutora em Letras, Professora do Centro Universitário UNIFACIG - Manhuaçu (MG) e da UEMG – Carangola (MG)
  • Andréia Almeida Mendes Professora, Doutora em Linguística, Professora do Centro Universitário UNIFACIG - Manhuaçu (MG)
  • Luiz Carlos de Abreu Programa de Mestrado em Políticas Públicas e Desenvolvimento Local. Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (EMESCAM). Vitória (ES)/ Laboratório de Delineamento de Estudos e Escrita Científica. Centro Universitário Saúde ABC, Santo André, SP
Keywords: psychotropic drugs, psychoanalysis therapy, drug misuse, mental health, signs and symptoms

Abstract

Introduction: Drug use has been discussed by various authorities and health professionals, and a change in attitude. Among them, psychoanalysts and psychotherapists recognize the importance that the theme has been having in recent decades, considering the rational use of psychotropic drugs as supporting psychoanalytic treatment. Objective: To analyze the use of psychotropic drugs and their relationship with psychoanalytic psychotherapy in the interface of mental health. Methods: This is an integrative review of the MEDLINE Database based on a statement of preferred reports for systematic methods and meta-analyzes (PRISMA) through the descriptors: Psychotropic Drugs and Psychoanalysis Drug Therapy and Drug Misuse and Drug Use and Signs and Symptoms, filtering the results by title and summary specificity and only studies available in their full version and conducted in humans were detected. Results: 42 articles were selected for final analysis. The object of article analysis was submitted to the analyst who treats his patients and conducts clinical trials with drug interaction, as well as therapeutic transfer complement as a clinical resource for treatment of psychoanalytic sessions. In addition, the results of this drug interaction were evidenced as supporting factors in the clinical treatment of clients exposed to the clinical session. Final considerations: The use of psychoactive drugs and psychoanalytic psychotherapy Shows as an association capable of proving interaction and integration of the personality aspects and the psychological structure of the individual. It is a clinical condition that can be stimulated in the mental health treatment of individuals suffering from mental / emotional distress.

Downloads

Download data is not yet available.

References

1. Santiago J. A droga do toxicômano: uma parceria cínica da era da ciência. Belo Horizonte: Relicário, 2017.

2. Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Uso racional de medicamentos: temas selecionados. Brasília: Ministério da Saúde, 2012.

3. Brasil. Ministério da Saúde. Presidência da República. Casa Civil. Subchefia para assuntos jurídicos. Lei nº 10.216. [cited 2018 Oct 28] Available from: http://www.planalto.gov.br/ccivil_03/leis/leis_2001/l10216.htm

4. Brasil. Ministério da Saúde. Gabinete do Ministro. Portaria nº 3.088 de 23 de dezembro de 2011. [cited 2018 Oct 28] Available from: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2011/prt3088_23_12_2011_rep.html

5. Freud S. Freud (1930-1936): o mal-estar na civilização e outros textos. São Paulo: Companhia das Letras, 2010; p. 13-122.

6. Derrida J. A farmácia de Platão. São Paulo: Iluminuras, 2005.

7. Frey BN, Mabilde LC, Eizirik CL. A integração da psicofarmacoterapia e psicoterapia de orientação analítica: uma revisão crítica. Rev Bras Psiquiatr. 2004;26(2):118-25. DOI: http://dx.doi.org/10.1590/S1516-44462004000200009

8. Sampaio RF, Mancini MC. Estudos de Revisão Sistemática: um guia para síntese criteriosa da evidência científica. Rev Bras Fisioter. 2007;11(1):83-9. DOI: http://dx.doi.org/10.1590/S1413-35552007000100013

9. Laurent E. Como engolir a pílula? In: Miller JA. Ornicar? De Jacques Lacan a Lewis Carroll. Rio de janeiro: Jorge Zahar, 2004.

10. Ryang S. A critique of medicalisation: three instances. Anthropol Med. 2017; 24(3):248-60. DOI: http://dx.doi.org/10.1080/13648470.2017.1389169

11. Brokman R. Aspects of psychodynamic neuropsychiatry II: psychical locality and biology: toward the neurobiology of psychotherapy. J Am Acad Psychoanal Dyn Psychiatry. 2011;39(2):285-311. DOI: http://dx.doi.org/10.1521/jaap.2011.39.2.285

12. Wylie HW Jr, Wylie ML. An effect of pharmacotherapy on the psychoanalytic process: case report of a modified analysis. Am J Psychiatry. 1987;144(4):489-92. DOI: http://dx.doi.org/10.1176/ajp.144.4.489

13. Classificação Internacional de Doenças CID – 10: Classificação de Transtornos Mentais e de Comportamento da CID-10: Descrições clínicas e diretrizes diagnósticas. Porto Alegre: Artmed, 1993.

14. Waldinger RJ, Frank AF. Transference and the vicissitudes of medication use by borderline patients. Psychiatry. 1989 Nov; 52(4):416-27. DOI: http://dx.doi.org/10.1080/00332747.1989.11024466

15. Lesse S. Combined drug and psychotherapy of severely depressed ambulatory patients. Am J Psychotherapy. 1966;11(Suppl):S123-30.

16. Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry. 1999;156(10):1563-9. DOI: http://dx.doi.org/10.1176/ajp.156.10.1563

17. Brokman R. Medication and transference in psychoanalytically oriented psychotherapy of the borderline patient. Psychiatr Clin North Am. 1990;13(2):287-95.

18. Snyder S. The interaction of psychopharmacology and psychoanalysis in the borderline patient. Psychiatr Q. 1980;52(4):240-50. DOI: http://dx.doi.org/10.1007/bf01080285

19. Ramos MA. Drugs in context: a historical perspective on theories of psychopharmaceutical efficacy. J Nerv Ment Dis. 2013;201(11):926-33. DOI: http://dx.doi.org/20.1097/NMD.0000000000000062

20. Rickles WH. Listening to Prozac, with the third ear: a psychoanalytic theory of psychopharmacology. J Am Acad Psychoanal Dyn Psychiatry. 2006;34(4):709-33. DOI: http://dx.doi.org/10.1521/jaap.2006.34.4.709

21. Chemana R. Dicionário de Psicanálise. Porto Alegre: Artes Médicas, 1995.

22. Rubin J. Countertransference factors in the psychology of psychopharmacology. J Am Acad Psychoanal. 2001;29(4):565-73. DOI: https://doi.org/10.1521/jaap.29.4.565.21538

23. Gottlieb RM. Mind, madness, and medications: situating psychoanalysis. J Am Psychoanal Assoc. 2006;54(3):739-44. DOI: https://doi.org/10.1177/00030651060540030601

24. Donovam SJ, Roose SP. Medication use during psychoanalysis: a survey. J Clin Psychiatry. 1995;56(5):177-8.

25. Hamilton NG, Sacks LH, Hamilton CA. Object relations theory and pharmacopsychotherapy of anxiety disorders. Am J Psychother. 1994;48(3):380-91. DOI: https://doi.org/10.1176/appi.psychotherapy.1994.48.3.380


26. Doidge N, Simon B, Brauer L, Brant DC, First M, Brunshaw J, et al. Psychoanalytic patients in the U.S., CANADA, and Australia: I. DSM-III-R disorders, indications, previous treatment, medications, and length of treatment. J Am Psychoanal Assoc. 2002;50(2):575-614. DOI: https://doi.org/10.1177/00030651020500021201

27. Wright JL. Psychoanalysis in conjunction with medication: a clinical research opportunity. J Am Psychoanal Assoc. 2006;54(3):833-55. DOI: https://doi.org/10.1177/00030651060540031601

28. Frosch WA. Psychoanalytic evaluation of addiction and habituation. J Am Psychoanal Assoc. 1970;18(1):209-18. DOI: https://doi.org/10.1177/000306517001800111

29. Silvio JR, Condemarín R. Psychodynamic psychiatrists and psychopharmacology. J Am Acad Psychoanal Dyn Psychiatry. 2011;39(1):27-39. DOI: https://doi.org/10.1521/jaap.2011.39.1.27

30. 30. Rivera JLG. Psychotherapy and Pharmacotherapy. J Am Acad Psychoanal Dyn Psychiatry. 2007;35(2):173-77.

31. Creed F, Guthrie E, Ratcliffe J, Fernandes L, Rigby C, Tomenson B, et al. Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder? Aust N Z J Psychiatry. 2005;39(9):807-15. DOI: https://doi.org/10.1080/j.1440-1614.2005.01686.x

32. Kane Jr FJ, Haper RG. Psychotherapy: past training and current practice. Gen Hosp Psychiatry. 1992;14(2):131-4. DOI: https://doi.org/10.1016/0163-8343(92)90038-C

33. Angermeyer MC, Matschinger H. Public attitude towards psychiatric treatment. Acta Psychiatr Scand. 1996;94(5):326-36. DOI: https://doi.org/10.1111/j.1600-0447.1996.tb09868.x

34. Tutter A. Romantic fantasies of madness and objections to psychotropic medication. J Am Psychoanal Assoc. 2009;57(3):631-55. DOI: https://doi.org/10.1177/0003065109333504

35. Nishizono M. The anaclitic drug-psychotherapy--a synthesis of psychoanalysis and high dose drugtherapy. Folia Psychiatr Neurol Jpn. 1965;19(1):9-15. DOI: https://doi.org/10.1111/j.1440-1819.1965.tb00030.x

36. Purcell SD. The analyst’s attitude toward pharmacotherapy. J Am Psychoanal Assoc. 2008;56(3):913-34. DOI: https://doi.org/10.1177/0003065108323376

37. Greene MA. The effects of the introduction of medication on the psychoanalytic process: a case study. J Am Psychoanal Assoc. 2001;49(2):607-27. DOI: https://doi.org/10.1177/00030651010490020901

38. Leo D. Treatment of adjustment disorders: a comparative evaluation. Psychol Rep. 1989;64(1):51-4. DOI: https://doi.org/10.2466/pr0.1989.64.1.51

39. Wilson SN. The meanings of medicating: pills and play. Am J Psychother. 2005;59(1):19-29. DOI:
https://doi.org/10.1176/appi.psychotherapy.2005.59.1.19

40. Laplanche J, Pontalis JB. Vocabulário da Psicanálise. São Paulo: Martins Fontes, 1996.

41. Press M. The uses of medications in psychoanalysis: what we know, what is uncertain. Panel reports. J Am Psychoanal Assoc. 2008;56(3):949-55. DOI: https://doi.org/10.1177/0003065108324063

42. Marcus ER. Transference and countertransference to medication and its implications for ego function. J Am Acad Psychoanal Dyn Psychiatry. 2007;35(2):211-8. DOI: https://doi.org/10.1521/jaap.2007.35.2.211

43. Kaplan M, Delgado SV. When worlds converge: combining depth psychotherapy and psychotropic medications. Bull Menninger Clin. 2006;70(4):253-72. DOI: https://doi.org/10.1521/bumc.2006.70.4.253

44. Canongia AI. O pharmakon na interface do dispositivo analítico: o pathos na busca de sua verdade. Rev Latinoam Psicopat Fund. 2006;9(3):410-22. DOI: http://dx.doi.org/10.1590/1415-47142006003003

45. Minas Gerais. Secretaria de Estado de Saúde. Atenção em Saúde Mental. Marta Elizabeth de Souza. Belo Horizonte: 2007.

46. Atrash HK. Health Disparities: Challenges, Opportunities, and What You Can Do About It. J Hum Growth Dev. 2018;28(3):223-31. DOI: http://dx.doi.org/10.7322/jhgd.152156

47. Roiste A. Nurturing resilience: the ‘ordinary magic’ of everyday life. J Hum Growth Dev. 2018;28(3):278-82. DOI: http://dx.doi.org/10.7322/jhgd.152175
Published
2019-11-05
Section
ORIGINAL ARTICLES